...
首页> 外文期刊>Pediatric Research >66 LOW TRIIODOTHYRONINE (T3) CONCENTRATIONS IN EXTREMELY LOW BIRTH WEIGHT (ELBW) INFANTS ASSOCIATED WITH DEXAMETHASONE TREATMENT
【24h】

66 LOW TRIIODOTHYRONINE (T3) CONCENTRATIONS IN EXTREMELY LOW BIRTH WEIGHT (ELBW) INFANTS ASSOCIATED WITH DEXAMETHASONE TREATMENT

机译:地塞米松治疗引起的极低出生体重(ELBW)婴儿中的66低三碘代甲状腺素(T3)浓度

获取原文
           

摘要

Preterm infants are jeopardized by the immature thyroid system. Dexamethasone is a widely used drug well known to inhibit the peripheral thyroxine (T4) conversion. We therefore studied the concentrations of T4 and T3 in 22 ELBW infants.Methods: We obtained blood samples at delivery, 4, 7, and 14 days thereafter in (G1) 12 ELBW infants treated with dexamethasone during the first days of live (0.5 mg/kg day) because of arterial hypotension or severe lung disease and in (G2) 10 ELBW infants without dexamethasone.There was no physiological increase in T3 serum concentrations after birth in G1, whereas T4 and TSH showed a similar course in both groups (not shown). T3 concentrations were significantly lower in the dexamethasone treated infants at day 7 and 14.Conclusion: Our data show evidence that the immature thyroid function of ELBW infants (hypothyroxinemia and transient primary hypothroidism) is further adversely affected by dexamethasone.
机译:早产儿会因甲状腺系统未成熟而受到危害。地塞米松是众所周知的抑制外周甲状腺素(T4)转化的广泛使用的药物。因此,我们研究了22名ELBW婴儿中T4和T3的浓度。方法:我们在分娩开始的第一天(G1)12例接受地塞米松治疗的(G1)12名ELBW婴儿中获得了血液样本(0.5 mg / kg日)(G2)10例没有地塞米松的ELBW婴儿(由于动脉低血压或严重的肺部疾病),G1出生后T3血清浓度没有生理增加,而T4和TSH在两组中均表现出相似的过程(无显示)。地塞米松治疗的婴儿在第7天和第14天的T3浓度显着降低。结论:我们的数据表明,地塞米松对ELBW婴儿的未成熟甲状腺功能(低甲状腺素血症和短暂原发性甲状腺功能减退症)产生了不利影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号